Lensar (LNSR) Current Leases (2020 - 2026)

Lensar (LNSR) reported Current Leases of $785000.0 for Q1 2026, up 51.84% year-over-year from $517000.0 in Q1 2025, and up 5.09% quarter-over-quarter from $747000.0 in Q4 2025.

Lensar (LNSR) Current Leases (2020 - 2026) Analysis & Trends

Lensar (LNSR) has 7 years of Current Leases data on file, last reported at $785000.0 in Q1 2026.

  • Current Leases for Q1 2026 came in at $785000.0, up 51.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $785000.0 (up 51.84% YoY), and the FY2025 annual result was $747000.0, up 42.56% from the prior year.
  • Current Leases climbed to $785000.0 in Q1 2026 per LNSR's latest filing, from $747000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $785000.0 in Q1 2026 and troughed at $516000.0 in Q1 2022.
  • A 5-year average of $576176.5 and a median of $549000.0 in 2023 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2025 and 2026: Current Leases dropped 8.33% in 2025, then soared 51.84% in 2026.
  • A 5-year view of Current Leases shows it stood at $531000.0 in 2022, then increased by 5.27% to $559000.0 in 2023, then declined by 6.26% to $524000.0 in 2024, then soared by 42.56% to $747000.0 in 2025, then increased by 5.09% to $785000.0 in 2026.
  • Business Quant data shows LNSR's Current Leases at $785000.0 in Q1 2026, $747000.0 in Q4 2025, and $693000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 Lensar 70.05 Mn 70.34 Mn 6.38 Mn 785,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 785,000.00
Dec 31, 2025 747,000.00
Sep 30, 2025 693,000.00
Jun 30, 2025 522,000.00
Mar 31, 2025 517,000.00
Dec 31, 2024 524,000.00
Sep 30, 2024 574,000.00
Jun 30, 2024 569,000.00
Mar 31, 2024 564,000.00
Dec 31, 2023 559,000.00
Sep 30, 2023 554,000.00
Jun 30, 2023 549,000.00
Mar 31, 2023 544,000.00
Dec 31, 2022 531,000.00
Sep 30, 2022 526,000.00
Jun 30, 2022 521,000.00
Mar 31, 2022 516,000.00
Dec 31, 2021 512,000.00
Dec 31, 2020 493,000.00